Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,434,245
  • Shares Outstanding, K 140,311
  • Annual Sales, $ 98,380 K
  • Annual Income, $ -146,230 K
  • 60-Month Beta 0.28
  • Price/Sales 53.78
  • Price/Cash Flow N/A
  • Price/Book 7.28
Trade ADPT with:

Options Overview

Details
  • Implied Volatility 79.88%
  • Historical Volatility 48.09%
  • IV Percentile 78%
  • IV Rank 57.36%
  • IV High 100.04% on 03/08/21
  • IV Low 52.75% on 06/09/21
  • Put/Call Vol Ratio 0.09
  • Today's Volume 101
  • Volume Avg (30-Day) 375
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 7,595
  • Open Int (30-Day) 8,748

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.43
  • Number of Estimates 4
  • High Estimate -0.37
  • Low Estimate -0.47
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -65.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.00 +13.91%
on 07/15/21
43.40 -10.75%
on 06/29/21
-2.23 (-5.44%)
since 06/23/21
3-Month
30.41 +27.36%
on 05/11/21
44.97 -13.88%
on 04/27/21
-4.34 (-10.08%)
since 04/23/21
52-Week
30.41 +27.36%
on 05/11/21
71.25 -45.64%
on 01/19/21
+1.67 (+4.51%)
since 07/23/20

Most Recent Stories

More News
Microchip Announces Production Shipments of Industry's First NVMe and 24G SAS Tri-mode RAID and HBA Storage Adapters

Cloud service providers and server original equipment manufacturers (OEMs) designing storage platforms demand exceptional performance, flexibility and security for the next generation of data centers....

ADPT : 38.73 (+2.70%)
MCHP : 139.22 (+0.61%)
Bull of the Day: Exact Sciences (EXAS)

EPS surprises abound as Cologuard and Precision Oncology grow sales 20% into next year

EXAS : 117.95 (-0.07%)
ADPT : 38.73 (+2.70%)
NVTA : 28.18 (-0.77%)
NTRA : 114.00 (-2.41%)
GH : 119.04 (-0.33%)
Inflation Concerns Ruin First Week of Earnings Season

Inflation Concerns Ruin First Week of Earnings Season

UVXY : 28.68 (-0.55%)
SPXS : 22.06 (-2.90%)
ADPT : 38.73 (+2.70%)
PHIO : 1.88 (-0.53%)
GRWG : 39.91 (-1.75%)
NFLX : 515.41 (+0.71%)
IBM : 141.34 (+0.45%)
JNJ : 171.79 (+1.06%)
TXN : 186.85 (+1.60%)
Galapagos (GLPG) Falls on Inflammatory Study Data Readout

Galapagos (GLPG) announces data from multiple studies evaluating its two inflammatory candidates - GLPG3970 and GLPG3667. Stock down.

GILD : 69.02 (+0.54%)
ALXN : 182.50 (+1.70%)
ADPT : 38.73 (+2.70%)
GLPG : 59.91 (-0.33%)
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021

Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

ADPT : 38.73 (+2.70%)
QIAGEN (QGEN), Sysmex Ink Cancer Companion Diagnostics Deal

QIAGEN (QGEN) and Sysmex collaborate to develop and commercialize cancer companion diagnostics.

BMRN : 77.04 (-1.81%)
QGEN : 51.99 (+1.27%)
TECH : 474.40 (+1.11%)
ADPT : 38.73 (+2.70%)
Adaptive Biotechnologies (ADPT) Upgraded to Buy: Here's Why

Adaptive Biotechnologies (ADPT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADPT : 38.73 (+2.70%)
Axsome (AXSM) Plans NDA Filing for Fibromyalgia Drug in 2022

Axsome (AXSM) concludes a favorable pre-NDA meeting with the FDA for AXS-14, which is being developed as a treatment of fibromyalgia. The company will file an NDA in the fourth quarter of 2022.

RGEN : 209.92 (+1.90%)
ADPT : 38.73 (+2.70%)
AXSM : 53.68 (-3.94%)
BNTX : 281.96 (+0.35%)
New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat...

ADPT : 38.73 (+2.70%)
Amryt (AMYT) NDA for Skin Disorder Drug Gets Priority Review

Amryt (AMYT) is seeking approval for Oleogel-S10 as a potential treatment for patients with rare and distressing genetic skin disorder, epidermolysis bullosa.

ADPT : 38.73 (+2.70%)
XNCR : 31.86 (-1.55%)
ORGO : 15.01 (+0.74%)
AMYT : 11.18 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 41.10
2nd Resistance Point 39.94
1st Resistance Point 39.34
Last Price 38.73
1st Support Level 37.58
2nd Support Level 36.42
3rd Support Level 35.82

See More

52-Week High 71.25
Fibonacci 61.8% 55.65
Fibonacci 50% 50.83
Fibonacci 38.2% 46.01
Last Price 38.73
52-Week Low 30.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar